Ubs Group Ag Greenwich Life Sciences, Inc. Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 1,845 shares of GLSI stock, worth $20,848. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,845

Previous 3,196 42.27%

Holding current value

$20,848

Previous $30,000 46.67%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$8.76 - $10.44 $11,834 - $14,104	-1,351 Reduced 42.27%	1,845 $16,000
Q1 2025 May 13, 2025	SELL	$9.54 - $13.43 $32,063 - $45,138	-3,361 Reduced 51.26%	3,196 $30,000
Q4 2024 Feb 14, 2025	BUY	$10.91 - $14.95 $40,912 - $56,062	3,750 Added 133.59%	6,557 $73,000
Q3 2024 Nov 14, 2024	BUY	$12.99 - $17.58 $12,990 - $17,580	1,000 Added 55.34%	2,807 $40,000
Q2 2024 Aug 13, 2024	BUY	$12.07 - $19.04 $16,958 - $26,751	1,405 Added 349.5%	1,807 $31,000
Q1 2024 May 13, 2024	SELL	$8.31 - $20.32 $11,949 - $29,220	-1,438 Reduced 78.15%	402 $8,000
Q4 2023 Feb 09, 2024	BUY	$7.77 - $12.3 $14,289 - $22,619	1,839 Added 183900.0%	1,840 $19,000
Q3 2023 Nov 09, 2023	SELL	$8.41 - $10.66 $1,909 - $2,419	-227 Reduced 99.56%	1 $0
Q2 2023 Aug 11, 2023	BUY	$9.58 - $13.2 $2,174 - $2,996	227 Added 22700.0%	228 $2,000
Q1 2023 May 12, 2023	SELL	$12.12 - $20.8 $8,762 - $15,038	-723 Reduced 99.86%	1 $0
Q4 2022 Feb 08, 2023	SELL	$9.04 - $16.88 $9,808 - $18,314	-1,085 Reduced 59.98%	724 $11,000
Q3 2022 Nov 10, 2022	BUY	$7.81 - $12.02 $7,333 - $11,286	939 Added 107.93%	1,809 $17,000
Q2 2022 Aug 10, 2022	BUY	$7.14 - $20.36 $321 - $916	45 Added 5.45%	870 $7,000
Q1 2022 May 16, 2022	SELL	$16.3 - $24.65 $31,605 - $47,796	-1,939 Reduced 70.15%	825 $16,000
Q4 2021 Feb 14, 2022	SELL	$21.76 - $39.43 $33,640 - $60,958	-1,546 Reduced 35.87%	2,764 $67,000
Q3 2021 Nov 15, 2021	BUY	$38.65 - $46.11 $137,207 - $163,690	3,550 Added 467.11%	4,310 $168,000
Q2 2021 Aug 13, 2021	BUY	$31.24 - $53.6 $14,089 - $24,173	451 Added 145.95%	760 $34,000
Q1 2021 May 12, 2021	SELL	$22.37 - $39.98 $12,773 - $22,828	-571 Reduced 64.89%	309 $11,000
Q4 2020 Feb 11, 2021	BUY	$3.48 - $72.22 $2,098 - $43,548	603 Added 217.69%	880 $32,000
Q3 2020 Nov 12, 2020	BUY	$4.6 - $5.0 $1,274 - $1,385	277 New	277 $1,000

Others Institutions Holding GLSI

# of Institutions

Shares Held

1.24M

Call Options Held

Put Options Held

View Full List

About Greenwich LifeSciences, Inc.

Ticker GLSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,848,200
Market Cap $145M
Description
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...

More about GLSI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account